DE MATTEIS, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 360
EU - Europa 287
AS - Asia 170
SA - Sud America 1
Totale 818
Nazione #
US - Stati Uniti d'America 357
CN - Cina 142
IE - Irlanda 72
UA - Ucraina 59
FI - Finlandia 30
IT - Italia 28
DE - Germania 27
SG - Singapore 27
GB - Regno Unito 26
SE - Svezia 20
BE - Belgio 12
FR - Francia 10
CA - Canada 3
LT - Lituania 2
BR - Brasile 1
HK - Hong Kong 1
NL - Olanda 1
Totale 818
Città #
Chandler 98
Dublin 72
Jacksonville 68
Ann Arbor 49
Nanjing 41
Nanchang 24
Singapore 22
Boardman 18
Brussels 12
Medford 12
Pavia 12
Princeton 12
Ashburn 11
Lawrence 11
Shanghai 11
Hebei 10
Jiaxing 10
Beijing 9
Shenyang 9
Milan 8
Tianjin 8
Hangzhou 7
Wilmington 7
Changsha 6
Helsinki 6
Woodbridge 6
Norwalk 5
Des Moines 4
Frankfurt am Main 3
Los Angeles 3
Toronto 3
Verona 3
Auburn Hills 2
Jinan 2
Kunming 2
Saint-Fons 2
Santa Clara 2
Turin 2
Central 1
Clifton 1
Huizen 1
Melegnano 1
Ningbo 1
Rockville 1
Seattle 1
São Paulo 1
Totale 600
Nome #
Calamitic and antinematic orientational order produced by the generalized Straley lattice model 98
Universal mean-field phase diagram for biaxial nematics obtained from a minimax principle 85
Biaxial and uniaxial phases produced by partly repulsive mesogenic models involving $D_{2h}$ molecular symmetries 84
Director libration in nematoacoustics 80
Criterion for tricritical points in liquid crystal phases 79
Constrained stability for biaxial nematic phases 65
Bifurcation analysis and computer simulation of biaxial liquid crystals 64
Tricritical points in biaxial liquid crystal phases 62
Landau theory for biaxial nematic liquid crystals with two order parameter tensors 62
Mesogenic lattice models with partly antinematic interactions producing uniaxial nematic phases. 55
Orientationally ordered phases produced by fully antinematic interactions: a simulation study. 51
Erratum to "Orientationally ordered phase produced by fully antinematic interactions:A simulation study" [Physical Review E v=84, 011703 (2011)] 40
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 12
Totale 837
Categoria #
all - tutte 3.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 0 1 13 1 18 7 1
2020/2021116 13 13 4 11 1 14 2 18 4 17 15 4
2021/202262 3 1 1 3 1 3 1 5 4 1 8 31
2022/2023229 17 25 5 24 23 30 0 12 84 1 6 2
2023/202449 3 13 2 2 6 5 0 2 0 2 4 10
2024/202557 5 16 5 6 2 23 0 0 0 0 0 0
Totale 837